| Literature DB >> 9789812 |
M W Decker1, P Curzon, M W Holladay, A L Nikkel, R S Bitner, A W Bannon, D L Donnelly-Roberts, P S Puttfarcken, T A Kuntzweiler, C A Briggs, M Williams, S P Arneric.
Abstract
ABT-594, a nicotinic acetylcholine receptor agonist, has antinociceptive effects in rat models of acute thermal, persistent chemical, and neuropathic pain. Direct injection of ABT-594 into the nucleus raphe magnus (NRM) is antinociceptive in a thermal threshold test and destruction of serotonergic neurons in the NRM attenuates the effect of systemic ABT-594. However, lidocaine-inactivation of the NRM prevents the antinociceptive effect of systemic (-)-nicotine but not that of systemic ABT-594.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9789812 DOI: 10.1016/s0928-4257(98)80014-4
Source DB: PubMed Journal: J Physiol Paris ISSN: 0928-4257